Researchers at Ï㽶ÊÓƵ of Utah Health have developed high-tech tools to uncover the genetic cause of the most difficult to diagnose cases of early childhood seizures.
The Ï㽶ÊÓƵ of Utah College of Pharmacy’s Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to test...
